{"hands_on_practices": [{"introduction": "The definitive diagnosis of factitious disorder or malingering hinges on objective evidence of deception, followed by a careful assessment of motivation. This foundational exercise presents a classic case of feigned hypoglycemia, requiring you to interpret key biochemical markers—namely serum insulin and C-peptide—to prove surreptitious exogenous insulin administration. Once deception is established, you will then use the clinical and psychosocial context to apply the fundamental distinction between the internal need for a sick role (factitious disorder) and the pursuit of external incentives (malingering). [@problem_id:4711829]", "problem": "A $32$-year-old medical assistant with no known history of diabetes mellitus presents with recurrent episodes of confusion and diaphoresis. During two separate admissions, plasma glucose values were documented at $38$ mg/dL and $41$ mg/dL, respectively. She reports an intense interest in learning medical procedures and frequently volunteers to stay late in the clinic. She denies any interest in work leave, legal claims, or financial compensation. She lives alone. On interview, she expresses that she “feels most herself” when she is being cared for in the hospital and keeps a personal blog about her medical experiences.\n\nBetween episodes, her hemoglobin A1c (HbA1c) is $5.2\\%$, serum creatinine is $0.8$ mg/dL, and estimated glomerular filtration rate (eGFR) is $110$ mL/min/1.73 m$^2$. A toxicology screen is negative for oral hypoglycemics except for a dedicated high-performance liquid chromatography–mass spectrometry (HPLC–MS) sulfonylurea panel, which is negative. At the time of hypoglycemia, a fasting blood sample is drawn, analyzed on an immunoassay validated to detect commonly used exogenous human insulin analogs, with the following results: serum insulin $42$ µU/mL (reference $3$ µU/mL during hypoglycemia), C-peptide $0.2$ ng/mL, and proinsulin $1.0$ pmol/L. Anti-insulin antibody testing is negative.\n\nStarting from the basic physiology that pancreatic beta cells synthesize proinsulin and cleave it into insulin and connecting peptide in an equimolar ratio, and considering the differential clearance pathways of insulin (primarily hepatic) and C-peptide (primarily renal), which of the following is the most parsimonious explanation for the biochemical pattern and the clinical presentation?\n\nA. Factitious disorder imposed on self with surreptitious exogenous insulin administration\n\nB. Malingering with covert exogenous insulin use to obtain disability benefits\n\nC. Pancreatic beta-cell adenoma (insulinoma) causing endogenous hyperinsulinemic hypoglycemia\n\nD. Surreptitious sulfonylurea ingestion leading to endogenous insulin secretion\n\nE. Autoimmune insulin syndrome due to anti-insulin antibodies", "solution": "The problem asks for the most parsimonious explanation for a patient's recurrent hypoglycemia, integrating her clinical presentation, psychosocial history, and detailed biochemical findings. The solution requires a systematic evaluation of the differential diagnosis for hypoglycemia.\n\n**1. Initial Assessment: Characterizing the Hypoglycemia**\n\nThe patient presents with symptoms of neuroglycopenia (confusion) and autonomic activation (diaphoresis) at times of documented low plasma glucose levels ($38$ mg/dL and $41$ mg/dL). This satisfies Whipple's triad (symptoms of hypoglycemia, low blood glucose, and assumed resolution of symptoms with glucose), confirming clinically significant hypoglycemia.\n\nThe next critical step is to determine if the hypoglycemia is insulin-mediated. During a hypoglycemic state in a healthy individual, the pancreatic beta-cells should cease insulin secretion. The reference value provided, serum insulin $3$ µU/mL during hypoglycemia, reflects this physiological suppression. However, the patient's serum insulin level was measured at $42$ µU/mL. This inappropriately high insulin level in the face of hypoglycemia confirms a diagnosis of **hyperinsulinemic hypoglycemia**.\n\n**2. Differentiating Endogenous vs. Exogenous Hyperinsulinism**\n\nThe core of the problem lies in determining the source of the excess insulin. The provided physiological principle is central to this differentiation: pancreatic beta cells synthesize proinsulin, which is cleaved to release insulin and C-peptide (connecting peptide) in an equimolar ($1:1$) ratio into the circulation.\n\n*   **Endogenous hyperinsulinism**: If the pancreas is the source of the excess insulin (e.g., due to an insulin-secreting tumor (insulinoma) or stimulation by a drug like a sulfonylurea), both insulin and C-peptide will be secreted in excess. This would lead to high levels of both insulin and C-peptide. Proinsulin levels may also be elevated, particularly in insulinomas where processing of proinsulin to insulin can be inefficient.\n\n*   **Exogenous hyperinsulinism**: If insulin is administered from an external source (i.e., injection), commercially available insulin formulations do not contain C-peptide. The high levels of circulating exogenous insulin provide strong negative feedback to the patient's own pancreatic beta-cells, suppressing the entire secretory pathway. This results in suppressed secretion of endogenous insulin, C-peptide, and proinsulin.\n\n**3. Analysis of the Patient's Biochemical Profile**\n\nLet's analyze the patient's laboratory results from the sample drawn during hypoglycemia:\n*   **Serum Insulin**: $42$ µU/mL. This is markedly elevated (reference $3$ µU/mL), confirming hyperinsulinemia. The problem states the assay detects commonly used exogenous insulin analogs, so this value reflects the total circulating insulin.\n*   **C-peptide**: $0.2$ ng/mL. This level is very low, indicating profound suppression of pancreatic beta-cell secretion. In a state of endogenous hyperinsulinemia, C-peptide would be expected to be elevated, typically $0.6$ ng/mL. The patient's normal renal function (eGFR $110$ mL/min/$1.73$ m$^2$) is crucial, as it confirms that this low C-peptide level is not an artifact of increased renal clearance; rather, it is a true reflection of suppressed production.\n*   **Proinsulin**: $1.0$ pmol/L. This level is also low, consistent with pancreatic suppression. In an insulinoma, proinsulin is often disproportionately elevated (e.g., $5$ pmol/L or representing $25\\%$ of total immunoreactive insulin).\n\nThe biochemical triad of **high insulin, low C-peptide, and low proinsulin** is the definitive signature of **exogenous insulin administration**.\n\n**4. Integrating the Clinical and Psychosocial Context**\n\nHaving established exogenous insulin administration as the cause, we must now determine the patient's motivation, which distinguishes between factitious disorder and malingering.\n*   **Malingering** is characterized by the intentional production of symptoms for a recognizable external incentive (e.g., financial gain, avoiding work or legal responsibilities).\n*   **Factitious disorder** is characterized by the intentional production of symptoms driven by an internal need to assume the \"sick role,\" without obvious external rewards.\n\nThe patient's history is highly suggestive of factitious disorder:\n*   She is a medical assistant, providing her with the specialized knowledge and access required to obtain and administer insulin surreptitiously.\n*   She explicitly \"denies any interest in work leave, legal claims, or financial compensation,\" arguing against a motive of external gain (malingering).\n*   Her motivation appears internal and psychological: she \"feels most herself\" when being cared for in the hospital and maintains a blog about her medical experiences, indicating a desire to inhabit the patient role.\n\n**5. Evaluation of Provided Options**\n\n*   **A. Factitious disorder imposed on self with surreptitious exogenous insulin administration**: This diagnosis is consistent with all aspects of the case. The biochemical findings (high insulin, low C-peptide/proinsulin) prove exogenous insulin use. The psychosocial history (medical professional, no external incentive, desire to be in the sick role) is the classic presentation of factitious disorder. This is the most parsimonious explanation.\n    *   Verdict: **Correct**.\n\n*   **B. Malingering with covert exogenous insulin use to obtain disability benefits**: While this option correctly identifies exogenous insulin use, it incorrectly assigns the motivation. The problem statement provides specific information that contradicts the motive of malingering (denial of interest in financial compensation, work leave, etc.).\n    *   Verdict: **Incorrect**.\n\n*   **C. Pancreatic beta-cell adenoma (insulinoma) causing endogenous hyperinsulinemic hypoglycemia**: This would be a cause of endogenous hyperinsulinemia. As derived above, it would present with elevated C-peptide and proinsulin levels, which is the opposite of this patient's findings.\n    *   Verdict: **Incorrect**.\n\n*   **D. Surreptitious sulfonylurea ingestion leading to endogenous insulin secretion**: Sulfonylurea use stimulates the pancreas, causing endogenous hyperinsulinemia, which would lead to elevated C-peptide. This is contrary to the patient's labs. Furthermore, this was specifically ruled out by a negative high-sensitivity HPLC–MS panel.\n    *   Verdict: **Incorrect**.\n\n*   **E. Autoimmune insulin syndrome due to anti-insulin antibodies**: This rare condition can cause hypoglycemia with a high total insulin level and suppressed C-peptide. However, the diagnosis requires the presence of anti-insulin antibodies. The problem states that \"Anti-insulin antibody testing is negative,\" which definitively excludes this diagnosis.\n    *   Verdict: **Incorrect**.\n\nIn conclusion, the combination of biochemical evidence pointing to exogenous insulin administration and psychosocial factors indicating a desire to assume the sick role without external incentives makes factitious disorder imposed on self the only fitting diagnosis.", "answer": "$$\\boxed{A}$$", "id": "4711829"}, {"introduction": "While the theoretical distinction between factitious disorder and malingering appears clear, clinical practice is often complicated by patients with mixed motives. This exercise presents a more complex and realistic scenario where both internal needs and significant external incentives are simultaneously present, challenging the simple diagnostic dichotomy. Your task is to apply the formal diagnostic hierarchy stipulated by the DSM-5 to make a definitive classification, understanding which criteria take precedence when motivations overlap, and to formulate a defensible documentation strategy for this medicolegally sensitive situation. [@problem_id:4711863]", "problem": "A $36$-year-old man presents to the Emergency Department (ED) after being found diaphoretic and confused with a capillary glucose of $32$ mg/dL. In the past $6$ months he has presented to $4$ different hospitals with similar episodes, leading to a cumulative $11$ ED visits and $5$ short inpatient admissions. He carries no diagnosis of diabetes mellitus; outpatient records show a Hemoglobin A1c (HbA1c) of $5.2\\%$ within the last $2$ months. On this admission, laboratory testing obtained prior to dextrose administration reveals plasma insulin $42$ $\\mu$U/mL, C-peptide $0.1$ ng/mL, proinsulin below assay detection, and a negative sulfonylurea screen. A bag with insulin syringes is later found in his backpack; he states, “Those are old, from my grandfather.” He frequently uses medical jargon and presents a binder with neatly organized discharge summaries. Nursing notes from prior admissions document that he is engaged, polite, and particularly appreciative of “how special” the team makes him feel.\n\nCollateral information reveals several external contingencies: he is currently unhoused and reports that admission “guarantees a warm bed and meals for a couple days.” He has an outstanding court date for a probation violation that has been postponed twice due to hospitalizations occurring within $24$ hours of the scheduled appearance. He repeatedly requests opioid analgesics for “severe generalized pain” and asks staff to complete disability paperwork, stating, “I can’t work like this.” When opioids are declined, he has left against medical advice and presented to a different ED within $12$ hours.\n\nYou are asked to make a classification decision and to justify it using transparent criteria and documented contingencies. Starting from the core definitions that distinguish intentional symptom falsification or induction, the role of external incentives, and the requirement that certain diagnoses be excluded when obvious external rewards are present, select the single best option below that both (i) classifies his behavior and (ii) outlines an appropriate documentation strategy to support the decision.\n\nA. Diagnose factitious disorder imposed on self because of the evident internal need to assume the sick role; document deception and the absence of external rewards.\n\nB. Code malingering, given prominent external incentives, with explicit documentation of evidence for deliberate induction (e.g., exogenous insulin pattern) and time-linked contingencies (e.g., shelter, postponement of court dates, access to controlled substances, disability forms), and defer a diagnosis of factitious disorder due to the presence of obvious external rewards.\n\nC. Diagnose somatic symptom disorder with predominant pain because his distress appears genuine; avoid terms implying intentionality and document the severity of symptoms.\n\nD. Diagnose both factitious disorder imposed on self and malingering to capture mixed motives; document that internal and external gains are simultaneously present and therefore both diagnoses are warranted.", "solution": "The user has requested a classification decision for a complex clinical case involving feigned illness, with a justification based on psychiatric diagnostic criteria.\n\n### PROBLEM VALIDATION\n\n**Step 1: Extract Givens**\n\n- **Patient Demographics:** A $36$-year-old man.\n- **Presenting Complaint:** Found diaphoretic and confused with a capillary glucose of $32$ mg/dL.\n- **History of Present Illness:** In the past $6$ months, $4$ different hospitals, $11$ ED visits, and $5$ short inpatient admissions for similar episodes.\n- **Medical History:** No diagnosis of diabetes mellitus. Hemoglobin A1c (HbA1c) was $5.2\\%$ within the last $2$ months.\n- **Objective Laboratory Data:** During the hypoglycemic episode (prior to dextrose):\n    - Plasma insulin: $42$ $\\mu$U/mL (inappropriately high for the glucose level).\n    - C-peptide: $0.1$ ng/mL (suppressed).\n    - Proinsulin: Below assay detection.\n    - Sulfonylurea screen: Negative.\n- **Physical Evidence:** A bag with insulin syringes found in his backpack.\n- **Patient Statements and Behaviors:**\n    - Explanation for syringes: “Those are old, from my grandfather.”\n    - Behavior: Uses medical jargon, presents an organized binder of discharge summaries.\n    - Affect: Engaged, polite, appreciative of feeling “special.”\n- **Collateral Information and External Contingencies:**\n    - **Housing/Sustenance:** Unhoused; states admission “guarantees a warm bed and meals for a couple days.”\n    - **Legal:** Has an outstanding court date for a probation violation, postponed twice due to hospitalizations occurring within $24$ hours of the scheduled appearance.\n    - **Substance Seeking:** Repeatedly requests opioid analgesics for “severe generalized pain.”\n    - **Financial:** Asks staff to complete disability paperwork.\n    - **Behavioral Pattern:** When opioids are declined, he has left against medical advice and presented to a different ED within $12$ hours.\n- **Task:** Classify the behavior and outline an appropriate documentation strategy based on the definitions of intentional symptom falsification, the role of external incentives, and diagnostic exclusion criteria.\n\n**Step 2: Validate Using Extracted Givens**\n\n1.  **Scientifically Grounded:** The problem is firmly based on established principles of endocrinology and psychiatry. The laboratory pattern—high plasma insulin, suppressed C-peptide, and non-elevated proinsulin during hypoglycemia—is the classic and scientifically sound signature of exogenous insulin administration. This is because proinsulin is cleaved into insulin and C-peptide in equimolar amounts within pancreatic beta cells. Endogenous hyperinsulinism (e.g., from an insulinoma) would show elevations in all three (insulin, C-peptide, proinsulin). The administration of exogenous insulin, however, introduces insulin into the circulation without the corresponding C-peptide, and the resulting hypoglycemia feedback-suppresses the body's own production of proinsulin, insulin, and C-peptide. The normal HbA1c of $5.2\\%$ correctly rules out pre-existing, poorly managed diabetes. The behavioral and psychosocial factors are consistent with clinical presentations of an illness-falsification spectrum. The diagnostic categories mentioned (factitious disorder, malingering, somatic symptom disorder) are standard classifications from the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5). The problem is scientifically and factually sound.\n\n2.  **Well-Posed:** The problem provides a rich and detailed clinical vignette with sufficient objective and subjective data to allow for a differential diagnosis. The question asks for a single best classification and documentation strategy, which constitutes a well-defined task.\n\n3.  **Objective:** The language is descriptive and clinical, presenting observations, lab results, and reported statements without subjective bias. The core of the problem lies in the objective application of established diagnostic criteria to the provided data.\n\n**Step 3: Verdict and Action**\n\nThe problem statement is **valid**. It is scientifically sound, well-posed, and objective. I will proceed with deriving the solution.\n\n### SOLUTION\n\nThe problem requires a differential diagnosis between somatic symptom disorder, factitious disorder, and malingering. This is based on two key axes: (1) whether the symptoms are intentionally produced (feigned), and (2) what the primary motivation for the behavior is.\n\n**Principle-Based Derivation**\n\n1.  **Intentionality of Symptom Production:**\n    The patient presents with severe hypoglycemia (glucose $32$ mg/dL). The core question is whether this is a naturally occurring disease or intentionally induced. The laboratory results are definitive:\n    - High plasma insulin ($42$ $\\mu$U/mL) explains the hypoglycemia.\n    - Low C-peptide ($0.1$ ng/mL) proves the insulin is not from the patient's own pancreas. When the pancreas secretes insulin, it also secretes an equimolar amount of C-peptide.\n    - This combination of high insulin and low C-peptide is pathognomonic for the administration of exogenous insulin.\n    - This objective evidence, combined with the discovery of insulin syringes and the patient's lack of a diabetes diagnosis, incontrovertibly establishes that the hypoglycemia is intentionally induced.\n    - Therefore, diagnoses in which symptoms are not intentionally produced, such as somatic symptom disorder, can be ruled out.\n\n2.  **Motivation for Behavior: Internal vs. External Gain:**\n    Since the illness is intentionally produced, the differential diagnosis narrows to factitious disorder and malingering. The distinction hinges on the primary motivation.\n    - **Factitious Disorder:** The motivation is primarily internal—a psychological need to assume the \"sick role.\" The associated attention, sympathy, and care from medical staff are the reward. The diagnosis requires that \"the deceptive behavior is evident even in the absence of obvious external rewards\" (DSM-5, 300.19, Criterion C). In this case, there is evidence supporting this motivation: the patient is \"appreciative of 'how special' the team makes him feel,\" he is well-versed in medical culture (jargon, organized binder), and he has a long-standing pattern of seeking medical care.\n    - **Malingering:** The motivation is the achievement of an external, tangible goal. Malingering is defined as the \"intentional production of false or grossly exaggerated physical or psychological symptoms, motivated by external incentives.\" The DSM-5 notes that malingering should be strongly suspected when there is a medicolegal context, a marked discrepancy between claimed disability and objective findings, lack of cooperation, or antisocial personality traits.\n    - **Applying to the case:** This patient has multiple, prominent, and compelling external incentives:\n        - **Shelter and Food:** Admission provides basic needs (\"a warm bed and meals\").\n        - **Evasion of Legal Consequences:** Hospitalizations are temporally linked to postponing a court date for a probation violation.\n        - **Obtaining Controlled Substances:** He repeatedly requests opioid analgesics.\n        - **Financial Gain:** He is attempting to secure disability status.\n    - **Diagnostic Hierarchy:** The DSM-5 criteria create a quasi-mutually exclusive framework. A diagnosis of factitious disorder is contingent upon the *absence* of \"obvious external rewards.\" Since this case features multiple, clear, and powerful external rewards, the behavior does not meet the criteria for factitious disorder. The most accurate and defensible classification is malingering, as the behavior is best explained by the pursuit of these external gains. While internal and external motivations can coexist in a person, the diagnostic system prioritizes the presence of obvious external incentives, pointing toward malingering.\n\n**Option-by-Option Analysis**\n\n**A. Diagnose factitious disorder imposed on self because of the evident internal need to assume the sick role; document deception and the absence of external rewards.**\nThis option correctly identifies some evidence for an internal need to be sick. However, its recommendation to document \"the absence of external rewards\" is a direct contradiction of the facts of the case. The case is replete with prominent external rewards (shelter, court avoidance, drugs, disability). Because of this, the behavior does not satisfy Criterion C for factitious disorder.\n**Verdict: Incorrect.**\n\n**B. Code malingering, given prominent external incentives, with explicit documentation of evidence for deliberate induction (e.g., exogenous insulin pattern) and time-linked contingencies (e.g., shelter, postponement of court dates, access to controlled substances, disability forms), and defer a diagnosis of factitious disorder due to the presence of obvious external rewards.**\nThis option presents the most accurate and clinically responsible approach. It correctly identifies malingering as the appropriate classification based on the \"prominent external incentives.\" It recommends the correct documentation strategy: citing the objective evidence of deception (the pathognomonic lab results for exogenous insulin) and clearly listing the external motivators. Crucially, it correctly applies the diagnostic hierarchy by stating that the diagnosis of factitious disorder should be deferred *because* of the presence of these rewards. This aligns perfectly with the DSM-5 criteria.\n**Verdict: Correct.**\n\n**C. Diagnose somatic symptom disorder with predominant pain because his distress appears genuine; avoid terms implying intentionality and document the severity of symptoms.**\nThis option is fundamentally incorrect. The definitive laboratory evidence proves that the patient's life-threatening hypoglycemia is intentionally induced. Somatic symptom disorder applies only when symptoms are *not* intentionally produced. To diagnose this would be to ignore the most critical objective finding in the case. Furthermore, advising to \"avoid terms implying intentionality\" is a recommendation to produce an inaccurate and misleading medical record.\n**Verdict: Incorrect.**\n\n**D. Diagnose both factitious disorder imposed on self and malingering to capture mixed motives; document that internal and external gains are simultaneously present and therefore both diagnoses are warranted.**\nWhile it is plausible that the patient has mixed motives, this is not how the formal diagnostic system is structured. First, malingering is a V-code (or Z-code), an \"other condition that may be a focus of clinical attention,\" not a formal mental disorder itself. Second, the criteria for factitious disorder explicitly require that the behavior is present in the absence of obvious external rewards. Since such rewards are present, a formal diagnosis of factitious disorder is precluded. One cannot simultaneously diagnose a condition and ignore one of its essential exclusionary criteria. Therefore, diagnosing both is improper.\n**Verdict: Incorrect.**", "answer": "$$\\boxed{B}$$", "id": "4711863"}, {"introduction": "High-stakes diagnoses like malingering require clinicians to carefully weigh the risks of different types of errors—a false accusation carries different consequences than failing to identify deception. This capstone practice moves beyond descriptive classification to a quantitative decision framework, introducing Signal Detection Theory (SDT) to formalize this clinical balancing act. You will learn how to define a cost matrix with asymmetric losses for false positive ($C_{FP}$) and false negative ($C_{FN}$) errors and use it, along with prior probabilities, to calculate an optimal decision threshold ($\\tau$) that minimizes the total expected loss. [@problem_id:4711834] This provides a powerful model for making transparent and ethically justifiable diagnostic judgments under uncertainty.", "problem": "A forensic psychiatry service evaluates patients suspected of deceptive symptom production using a continuous composite index $X$ derived from performance validity testing and improbable symptom endorsement. Let $H_{1}$ denote \"malingering\" (intentional symptom production motivated by external incentives) and $H_{0}$ denote \"factitious disorder\" (intentional symptom production without external incentives). Assume that, conditional on the true state, the index $X$ has Gaussian class-conditional densities with equal variance. Specifically,\n- under $H_{1}$ (malingering), $X \\sim \\mathcal{N}(\\mu_{1}, \\sigma^{2})$ with $\\mu_{1} = 60$ and $\\sigma = 10$,\n- under $H_{0}$ (factitious disorder), $X \\sim \\mathcal{N}(\\mu_{0}, \\sigma^{2})$ with $\\mu_{0} = 40$ and the same $\\sigma = 10$.\n\nAmong intentionally deceptive referrals to this service, the prior probability of malingering is $\\pi_{1} = 0.65$ and the prior probability of factitious disorder is $\\pi_{0} = 0.35$. Decisions are made by thresholding $X$ at a scalar value $\\tau$: if $X \\ge \\tau$, the clinician classifies as malingering; if $X  \\tau$, the clinician classifies as factitious disorder.\n\nLet the loss (cost) matrix reflect asymmetric harms:\n- true malingering ($H_{1}$) decided as malingering: cost $0$,\n- true malingering ($H_{1}$) decided as factitious disorder (false negative): cost $C_{FN} = 10$,\n- true factitious disorder ($H_{0}$) decided as factitious disorder: cost $0$,\n- true factitious disorder ($H_{0}$) decided as malingering (false positive): cost $C_{FP} = 30$.\n\nUsing Signal Detection Theory (SDT), derive from first principles the decision rule that minimizes the expected loss (Bayes risk) under this cost matrix and these priors, and compute the corresponding optimal scalar threshold $\\tau$ on $X$. Round your final numerical value of $\\tau$ to four significant figures. Express your answer in the score units of $X$.", "solution": "The problem requires the derivation of an optimal decision threshold, $\\tau$, for classifying a patient's state as either $H_1$ (malingering) or $H_0$ (factitious disorder) based on a continuous index $X$. The optimality criterion is the minimization of the expected loss, also known as the Bayes risk. The decision rule is to classify as $H_1$ if $X \\ge \\tau$ and as $H_0$ if $X  \\tau$.\n\nLet $D_1$ be the decision to classify the state as $H_1$, and $D_0$ be the decision to classify as $H_0$. The problem provides a loss matrix, which we denote as $C(D_i, H_j)$, representing the cost of making decision $D_i$ when the true state is $H_j$. The given costs are:\n$C(D_1, H_1) = 0$\n$C(D_0, H_1) = C_{FN} = 10$ (False Negative)\n$C(D_0, H_0) = 0$\n$C(D_1, H_0) = C_{FP} = 30$ (False Positive)\n\nThe core of Bayesian decision theory is to make a decision that minimizes the posterior expected loss for a given observation $X=x$. The posterior expected loss for making decision $D_i$ is given by:\n$$\nR(D_i | x) = \\sum_{j=0}^{1} C(D_i, H_j) P(H_j | x)\n$$\nwhere $P(H_j|x)$ is the posterior probability of state $H_j$ given the observation $x$.\n\nLet's calculate the posterior expected loss for each of the two possible decisions, $D_1$ and $D_0$:\nFor decision $D_1$ (classify as malingering):\n$$\nR(D_1 | x) = C(D_1, H_1) P(H_1 | x) + C(D_1, H_0) P(H_0 | x) = 0 \\cdot P(H_1 | x) + C_{FP} \\cdot P(H_0 | x) = C_{FP} P(H_0 | x)\n$$\nFor decision $D_0$ (classify as factitious disorder):\n$$\nR(D_0 | x) = C(D_0, H_1) P(H_1 | x) + C(D_0, H_0) P(H_0 | x) = C_{FN} \\cdot P(H_1 | x) + 0 \\cdot P(H_0 | x) = C_{FN} P(H_1 | x)\n$$\nThe Bayes optimal decision rule is to choose the decision that minimizes this posterior expected loss. Therefore, we decide $D_1$ if $R(D_1 | x)  R(D_0 | x)$ and decide $D_0$ if $R(D_0 | x)  R(D_1 | x)$. The decision boundary, or threshold, occurs where the expected losses are equal, $R(D_1 | x) = R(D_0 | x)$.\n\nThe rule to decide $D_1$ is thus:\n$$\nC_{FP} P(H_0 | x)  C_{FN} P(H_1 | x)\n$$\nUsing Bayes' theorem, the posterior probability $P(H_j|x)$ can be expressed in terms of the class-conditional probability density function (likelihood) $p(x|H_j)$ and the prior probability $P(H_j) = \\pi_j$:\n$$\nP(H_j | x) = \\frac{p(x|H_j) \\pi_j}{p(x)}\n$$\nwhere $p(x) = \\sum_{j=0}^{1} p(x|H_j)\\pi_j$ is the marginal probability density of $x$. Substituting this into the inequality:\n$$\nC_{FP} \\frac{p(x|H_0) \\pi_0}{p(x)}  C_{FN} \\frac{p(x|H_1) \\pi_1}{p(x)}\n$$\nSince $p(x)$ is a density, it is non-negative, and for the regions of interest, it is strictly positive. We can multiply both sides by $p(x)$ and rearrange the terms to form a likelihood ratio test:\n$$\n\\frac{p(x|H_1)}{p(x|H_0)}  \\frac{C_{FP} \\pi_0}{C_{FN} \\pi_1}\n$$\nThis inequality defines the decision rule: if the likelihood ratio $L(x) = p(x|H_1)/p(x|H_0)$ exceeds the threshold $\\lambda_{Bayes} = (C_{FP} \\pi_0) / (C_{FN} \\pi_1)$, we classify as $H_1$.\n\nThe problem states that the class-conditional densities are Gaussian with equal variance:\n$p(x|H_1) = \\mathcal{N}(\\mu_1, \\sigma^2) = \\frac{1}{\\sqrt{2\\pi}\\sigma} \\exp\\left(-\\frac{(x - \\mu_1)^2}{2\\sigma^2}\\right)$\n$p(x|H_0) = \\mathcal{N}(\\mu_0, \\sigma^2) = \\frac{1}{\\sqrt{2\\pi}\\sigma} \\exp\\left(-\\frac{(x - \\mu_0)^2}{2\\sigma^2}\\right)$\n\nThe likelihood ratio $L(x)$ is:\n$$\nL(x) = \\frac{\\frac{1}{\\sqrt{2\\pi}\\sigma} \\exp\\left(-\\frac{(x - \\mu_1)^2}{2\\sigma^2}\\right)}{\\frac{1}{\\sqrt{2\\pi}\\sigma} \\exp\\left(-\\frac{(x - \\mu_0)^2}{2\\sigma^2}\\right)} = \\exp\\left(\\frac{(x - \\mu_0)^2 - (x - \\mu_1)^2}{2\\sigma^2}\\right)\n$$\nThe decision rule is to classify as $H_1$ if $L(x)  \\lambda_{Bayes}$. Since the natural logarithm is a strictly increasing function, we can take the logarithm of both sides without changing the inequality:\n$$\n\\ln(L(x))  \\ln(\\lambda_{Bayes})\n$$\n$$\n\\frac{(x - \\mu_0)^2 - (x - \\mu_1)^2}{2\\sigma^2}  \\ln\\left(\\frac{C_{FP} \\pi_0}{C_{FN} \\pi_1}\\right)\n$$\nWe expand the quadratic terms in the numerator:\n$(x^2 - 2x\\mu_0 + \\mu_0^2) - (x^2 - 2x\\mu_1 + \\mu_1^2) = 2x(\\mu_1 - \\mu_0) - (\\mu_1^2 - \\mu_0^2)$.\nThe inequality becomes:\n$$\n\\frac{2x(\\mu_1 - \\mu_0) - (\\mu_1^2 - \\mu_0^2)}{2\\sigma^2}  \\ln\\left(\\frac{C_{FP} \\pi_0}{C_{FN} \\pi_1}\\right)\n$$\nGiven $\\mu_1 = 60  \\mu_0 = 40$, the term $\\mu_1 - \\mu_0$ is positive. Thus, the left-hand side is an increasing function of $x$. The inequality is satisfied for $x$ greater than some threshold value. This is consistent with the decision rule format $X \\ge \\tau$. The optimal threshold $\\tau$ is the value of $x$ for which equality holds:\n$$\n\\frac{2\\tau(\\mu_1 - \\mu_0) - (\\mu_1^2 - \\mu_0^2)}{2\\sigma^2} = \\ln\\left(\\frac{C_{FP} \\pi_0}{C_{FN} \\pi_1}\\right)\n$$\nSolving for $\\tau$:\n$2\\tau(\\mu_1 - \\mu_0) = (\\mu_1^2 - \\mu_0^2) + 2\\sigma^2 \\ln\\left(\\frac{C_{FP} \\pi_0}{C_{FN} \\pi_1}\\right)$\n$\\tau = \\frac{\\mu_1^2 - \\mu_0^2}{2(\\mu_1 - \\mu_0)} + \\frac{2\\sigma^2}{2(\\mu_1 - \\mu_0)} \\ln\\left(\\frac{C_{FP} \\pi_0}{C_{FN} \\pi_1}\\right)$\nUsing the identity $\\mu_1^2 - \\mu_0^2 = (\\mu_1 - \\mu_0)(\\mu_1 + \\mu_0)$:\n$$\n\\tau = \\frac{\\mu_1 + \\mu_0}{2} + \\frac{\\sigma^2}{\\mu_1 - \\mu_0} \\ln\\left(\\frac{C_{FP} \\pi_0}{C_{FN} \\pi_1}\\right)\n$$\nThis is the general expression for the optimal threshold $\\tau$ under the given conditions.\n\nNow, we substitute the numerical values provided in the problem:\n$\\mu_1 = 60$, $\\mu_0 = 40$, $\\sigma = 10$, $\\pi_1 = 0.65$, $\\pi_0 = 0.35$, $C_{FP} = 30$, $C_{FN} = 10$.\n\n$\\tau = \\frac{60 + 40}{2} + \\frac{10^2}{60 - 40} \\ln\\left(\\frac{30 \\times 0.35}{10 \\times 0.65}\\right)$\n$\\tau = \\frac{100}{2} + \\frac{100}{20} \\ln\\left(\\frac{10.5}{6.5}\\right)$\n$\\tau = 50 + 5 \\ln\\left(\\frac{21}{13}\\right)$\n\nTo obtain the numerical value, we compute the logarithm:\n$\\ln\\left(\\frac{21}{13}\\right) \\approx \\ln(1.6153846...) \\approx 0.4795604$\n$\\tau \\approx 50 + 5 \\times 0.4795604$\n$\\tau \\approx 50 + 2.397802$\n$\\tau \\approx 52.397802$\n\nThe problem requires rounding the result to four significant figures.\n$\\tau \\approx 52.40$\nThe optimal scalar threshold is $52.40$ on the score units of $X$.", "answer": "$$\n\\boxed{52.40}\n$$", "id": "4711834"}]}